期刊文献+

G-CSF的不同方案动员正常供者外周血干细胞的效果比较 被引量:3

Comparison of Efficiencies Mobilizing Stem Cells into Pheripheral Blood in Healthy Donors by Different Schemes with G-CSF
暂未订购
导出
摘要 为了研究粒细胞集落刺激因子(rhG-CSF)动员的最佳动员方案,对HLA完全相合的非清髓异基因外周造血干细胞移植的供者60例进行回顾性分析。结果显示:供者rhG-CSF10μg/(kg·d)的动员方案组所采集的单个核细胞及CD34+细胞数明显高于供者rhG-CSF5μg/(kg·d)的动员方案组(P<0.05)。供者rhG-CSF10μg/(kg·d)的动员方案在第4天或第5天采集时所获得的单个核细胞及CD34+细胞数无统计学差别。供者不同rhG-CSF动员剂量及采集时间所获得的CD3+、CD4+、CD8+细胞的百分比无统计学差别。结论:供者10μg/(kg·d)的动员效果明显优于供者5μg/(kg·d)的动员效果。供者10μg/(kg·d)的动员方案在第4天或第5天采集时效果无统计学差异,但第4天采集可缩短动员天数,降低费用,因此对供者采用10μg/(kg·d)动员方案时在第4天采集单个核细胞效果更好。 The aim of study was to select the best scheme of G-CSF to mobilize peripheral stem/progenitor cells in healthy donors, The clinical data of 60 cases received nonmyeloablative ailogenic hematopoietic stem cell transplantation was analyzed retrospectively. The results indicated that the counts of MNC and CD34^ + cells were significantly higher in the 10 μg/(kg·d)group than that in the 5 μg/(kg·d)group(P 〈0.05). The counts of MNC and CD34^+ cells which were collected after day 4 or 5 in the 10 μg/(kg·d) groups were not significantly different. The percentage ofCD3^+ cells, CD4^+cells and CD8 ^+cells were not different in different groups. It is concluded that the scheme using 10 μg/(kg·d) G-CSF is more efficient than that in the 5 μg/(kg·d) group in mobilizing stem cells. It may reduce days for mobilization and decrease expense for collection of cells after 4 days of mobilization. Scheme using 10 μg/(kg·d) G-CSF for cells collecting after 4 days is more efficient.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第1期165-167,共3页 Journal of Experimental Hematology
基金 国家"863"计划 编号2002AA216081
关键词 粒细胞集落刺激因子 动员方案 非清髓异基因外周血干细胞移植 G-CSF mobilization scheme nonmyeloablative aUogenic hematopoietic stem cell trausplantation
  • 相关文献

参考文献5

  • 1Kroger N, Zeller W, Hassan HT, et al. Stem cell mobilization with G-CSF alone in breast cancer patients:higher progenitor cell yield by delivering divided doses(2 × 5 μg/kg) compared to a single dose( 1 × 10 μg/kg). Bone Marrow Transplant,1999 ;23 :125 - 129
  • 2肖秀斌,郭梅,乔建辉,王丹红,孙琪云,艾辉胜.单次和分次应用G-CSF动员供体外周血造血干细胞的效果比较[J].解放军医学杂志,2004,29(7):603-604. 被引量:5
  • 3Stroncek D, Anderlini P. Mobilized PBPC concentrates: a maturing blood component. Transfusion,2001 ;41:168 - 171
  • 4黄文荣,达万明,邓新立,高春记,韩晓萍,吴晓雄,李红华,朱海燕,靳海杰,靖域,王书红,薄剑.中剂量rhG-CSF动员对供者外周血免疫细胞组成的影响[J].中国实验血液学杂志,2005,13(5):852-856. 被引量:6
  • 5Nawa Y, Teshima T, Sunami K. et al. G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant, 2000 ;25 : 1035 - 1040

二级参考文献13

  • 1[1]Fischer.J,Frick M.Steady-state mobilization of PBPC: schedule dependent effective of G-CSF.Exp Hematol,1995,23:869
  • 2[2]Ponisch W,Leiblein S,Edel E et al.Mobilization of peripheral blood progenitor cells(PBPC)in normal donor for allogeneic PBPC transplantation: comparison between once a day versus twice a day of G-CSF(filgrastim)administration.Blood,1999,94:137
  • 3[3]Kroger N,Renges H,Kruger W et al.A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation,Br J Haematol,2000,111:761
  • 4[5]Terstappen LW,Huang S,Safford M et al.Sequential generation of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.Blood,1991,77(6):1218
  • 5[6]Grigg AP,Roberts AW,Raunow H et al.Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.Blood,1995,86:4437
  • 6[7]Anderlini P,Przepiorka D,Seong C et al.Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.Transfusion,1997,37:507
  • 7Koc ON , Gerson SL , Phillips GL, et al. Autologous CD34 + cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant, 1998; 21:337 -343.
  • 8Clark L, Clark O, Djulbegovic B, et al. Allogeneic peripheral blood stem cells vs. bone marrow transplantation for the therapy of hematological malignancies: a meta - analysis of randomized controlled trials. Blood, 2001; 98: 414.
  • 9Rutella S, Rumi C, Testa U, et al. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant, 1997; 20:355-364.
  • 10Saito M, Kiyokawa N, Taguchi T, et al. Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. Exp Hematol, 2002; 30: 1115 - 1123.

共引文献8

同被引文献41

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部